The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Circulating Biomarker Market Research Report 2025
Synopsis
The global Circulating Biomarker market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Circulating Biomarker is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Circulating Biomarker is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Circulating Biomarker include Abbott Laboratories, Becton, Dickinson and Company, GE Healthcare, Epigenomics AG, Agilent Technologies, Biocept, Affymetrix and Fluxion Biosciences, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Circulating Biomarker, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Circulating Biomarker.
Report Scope
The Circulating Biomarker market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Circulating Biomarker market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Circulating Biomarker manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Abbott Laboratories
Becton, Dickinson and Company
GE Healthcare
Epigenomics AG
Agilent Technologies
Biocept
Affymetrix
Fluxion Biosciences
Segment by Type
Circulating DNA
Circulating Tumor Cells
Other
Segment by Application
Hospital
Medical Research Center
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Circulating Biomarker manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Circulating Biomarker in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
The global Circulating Biomarker market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Circulating Biomarker is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Circulating Biomarker is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Circulating Biomarker include Abbott Laboratories, Becton, Dickinson and Company, GE Healthcare, Epigenomics AG, Agilent Technologies, Biocept, Affymetrix and Fluxion Biosciences, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Circulating Biomarker, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Circulating Biomarker.
Report Scope
The Circulating Biomarker market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Circulating Biomarker market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Circulating Biomarker manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Abbott Laboratories
Becton, Dickinson and Company
GE Healthcare
Epigenomics AG
Agilent Technologies
Biocept
Affymetrix
Fluxion Biosciences
Segment by Type
Circulating DNA
Circulating Tumor Cells
Other
Segment by Application
Hospital
Medical Research Center
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Circulating Biomarker manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Circulating Biomarker in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Circulating Biomarker Market Overview
1.1 Product Overview and Scope of Circulating Biomarker
1.2 Circulating Biomarker Segment by Type
1.2.1 Global Circulating Biomarker Market Value Comparison by Type (2024-2030)
1.2.2 Circulating DNA
1.2.3 Circulating Tumor Cells
1.2.4 Other
1.3 Circulating Biomarker Segment by Application
1.3.1 Global Circulating Biomarker Market Value by Application: (2024-2030)
1.3.2 Hospital
1.3.3 Medical Research Center
1.3.4 Others
1.4 Global Circulating Biomarker Market Size Estimates and Forecasts
1.4.1 Global Circulating Biomarker Revenue 2019-2030
1.4.2 Global Circulating Biomarker Sales 2019-2030
1.4.3 Global Circulating Biomarker Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Circulating Biomarker Market Competition by Manufacturers
2.1 Global Circulating Biomarker Sales Market Share by Manufacturers (2019-2024)
2.2 Global Circulating Biomarker Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Circulating Biomarker Average Price by Manufacturers (2019-2024)
2.4 Global Circulating Biomarker Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Circulating Biomarker, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Circulating Biomarker, Product Type & Application
2.7 Circulating Biomarker Market Competitive Situation and Trends
2.7.1 Circulating Biomarker Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Circulating Biomarker Players Market Share by Revenue
2.7.3 Global Circulating Biomarker Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Circulating Biomarker Retrospective Market Scenario by Region
3.1 Global Circulating Biomarker Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Circulating Biomarker Global Circulating Biomarker Sales by Region: 2019-2030
3.2.1 Global Circulating Biomarker Sales by Region: 2019-2024
3.2.2 Global Circulating Biomarker Sales by Region: 2025-2030
3.3 Global Circulating Biomarker Global Circulating Biomarker Revenue by Region: 2019-2030
3.3.1 Global Circulating Biomarker Revenue by Region: 2019-2024
3.3.2 Global Circulating Biomarker Revenue by Region: 2025-2030
3.4 North America Circulating Biomarker Market Facts & Figures by Country
3.4.1 North America Circulating Biomarker Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Circulating Biomarker Sales by Country (2019-2030)
3.4.3 North America Circulating Biomarker Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Circulating Biomarker Market Facts & Figures by Country
3.5.1 Europe Circulating Biomarker Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Circulating Biomarker Sales by Country (2019-2030)
3.5.3 Europe Circulating Biomarker Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Circulating Biomarker Market Facts & Figures by Country
3.6.1 Asia Pacific Circulating Biomarker Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Circulating Biomarker Sales by Country (2019-2030)
3.6.3 Asia Pacific Circulating Biomarker Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Circulating Biomarker Market Facts & Figures by Country
3.7.1 Latin America Circulating Biomarker Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Circulating Biomarker Sales by Country (2019-2030)
3.7.3 Latin America Circulating Biomarker Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Circulating Biomarker Market Facts & Figures by Country
3.8.1 Middle East and Africa Circulating Biomarker Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Circulating Biomarker Sales by Country (2019-2030)
3.8.3 Middle East and Africa Circulating Biomarker Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Circulating Biomarker Sales by Type (2019-2030)
4.1.1 Global Circulating Biomarker Sales by Type (2019-2024)
4.1.2 Global Circulating Biomarker Sales by Type (2025-2030)
4.1.3 Global Circulating Biomarker Sales Market Share by Type (2019-2030)
4.2 Global Circulating Biomarker Revenue by Type (2019-2030)
4.2.1 Global Circulating Biomarker Revenue by Type (2019-2024)
4.2.2 Global Circulating Biomarker Revenue by Type (2025-2030)
4.2.3 Global Circulating Biomarker Revenue Market Share by Type (2019-2030)
4.3 Global Circulating Biomarker Price by Type (2019-2030)
5 Segment by Application
5.1 Global Circulating Biomarker Sales by Application (2019-2030)
5.1.1 Global Circulating Biomarker Sales by Application (2019-2024)
5.1.2 Global Circulating Biomarker Sales by Application (2025-2030)
5.1.3 Global Circulating Biomarker Sales Market Share by Application (2019-2030)
5.2 Global Circulating Biomarker Revenue by Application (2019-2030)
5.2.1 Global Circulating Biomarker Revenue by Application (2019-2024)
5.2.2 Global Circulating Biomarker Revenue by Application (2025-2030)
5.2.3 Global Circulating Biomarker Revenue Market Share by Application (2019-2030)
5.3 Global Circulating Biomarker Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Abbott Laboratories
6.1.1 Abbott Laboratories Corporation Information
6.1.2 Abbott Laboratories Description and Business Overview
6.1.3 Abbott Laboratories Circulating Biomarker Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Abbott Laboratories Circulating Biomarker Product Portfolio
6.1.5 Abbott Laboratories Recent Developments/Updates
6.2 Becton, Dickinson and Company
6.2.1 Becton, Dickinson and Company Corporation Information
6.2.2 Becton, Dickinson and Company Description and Business Overview
6.2.3 Becton, Dickinson and Company Circulating Biomarker Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Becton, Dickinson and Company Circulating Biomarker Product Portfolio
6.2.5 Becton, Dickinson and Company Recent Developments/Updates
6.3 GE Healthcare
6.3.1 GE Healthcare Corporation Information
6.3.2 GE Healthcare Description and Business Overview
6.3.3 GE Healthcare Circulating Biomarker Sales, Revenue and Gross Margin (2019-2024)
6.3.4 GE Healthcare Circulating Biomarker Product Portfolio
6.3.5 GE Healthcare Recent Developments/Updates
6.4 Epigenomics AG
6.4.1 Epigenomics AG Corporation Information
6.4.2 Epigenomics AG Description and Business Overview
6.4.3 Epigenomics AG Circulating Biomarker Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Epigenomics AG Circulating Biomarker Product Portfolio
6.4.5 Epigenomics AG Recent Developments/Updates
6.5 Agilent Technologies
6.5.1 Agilent Technologies Corporation Information
6.5.2 Agilent Technologies Description and Business Overview
6.5.3 Agilent Technologies Circulating Biomarker Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Agilent Technologies Circulating Biomarker Product Portfolio
6.5.5 Agilent Technologies Recent Developments/Updates
6.6 Biocept
6.6.1 Biocept Corporation Information
6.6.2 Biocept Description and Business Overview
6.6.3 Biocept Circulating Biomarker Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Biocept Circulating Biomarker Product Portfolio
6.6.5 Biocept Recent Developments/Updates
6.7 Affymetrix
6.6.1 Affymetrix Corporation Information
6.6.2 Affymetrix Description and Business Overview
6.6.3 Affymetrix Circulating Biomarker Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Affymetrix Circulating Biomarker Product Portfolio
6.7.5 Affymetrix Recent Developments/Updates
6.8 Fluxion Biosciences
6.8.1 Fluxion Biosciences Corporation Information
6.8.2 Fluxion Biosciences Description and Business Overview
6.8.3 Fluxion Biosciences Circulating Biomarker Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Fluxion Biosciences Circulating Biomarker Product Portfolio
6.8.5 Fluxion Biosciences Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Circulating Biomarker Industry Chain Analysis
7.2 Circulating Biomarker Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Circulating Biomarker Production Mode & Process
7.4 Circulating Biomarker Sales and Marketing
7.4.1 Circulating Biomarker Sales Channels
7.4.2 Circulating Biomarker Distributors
7.5 Circulating Biomarker Customers
8 Circulating Biomarker Market Dynamics
8.1 Circulating Biomarker Industry Trends
8.2 Circulating Biomarker Market Drivers
8.3 Circulating Biomarker Market Challenges
8.4 Circulating Biomarker Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
